ArticleNature communications2026
Alkyne Migratory Insertion Enabled Dynamic Kinetic Asymmetric Dearomatization of Unactivated Racemic Biaryls.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Catalytic asymmetric dearomatization has emerged as an effective approach for transforming planar aromatic compounds into valuable three-dimensional chiral architectures. Herein, we report a palladium-catalyzed enantioconvergent dearomatization of non-activated naphthalene derivatives via alkyne migratory insertion. Unlike existing methods that convert racemic biaryl substrates into enantiopure compounds, this work represents a rare strategy for dynamic kinetic asymmetric dearomatization of racemic unactivated biaryl systems. A custom-designed asymmetric polyfluorinated phosphoramidite ligand enables high reactivity and stereocontrol. Mechanistic studies confirmed an enantioconvergent pathway, converting configurationally labile biaryl substrates into enantioenriched spiro frameworks. A linear correlation between product and ligand enantiopurity supports a 1:1 Pd/ligand ratio in the active catalytic species, with density functional theory calculations offering further mechanistic insight. The synthetic utility was further demonstrated through scale-up reactions and downstream derivatizations, including a central-to-axial chirality transfer process.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.